You are here: Industry Insights > Children

News List

Growing Requirements for Medicines for Children fiercebiotech
May 29, 2018
Significant progress has been made in developing medicines for children since implementation of pediatric legislation in the US (1997) and EU (2006). However, gaps still exist, and regulatory authorities continue to address them.
UAE conducts an innovative medical study biospectrumasia
May 15, 2018
The new procedure involves using a special coloured dye solution mixed into a sweet drink, which is then drunk by the child.
Researchers develop lens to reduce myopia in children biospectrumasia
May 14, 2018
The team has designed a Defocus Incorporated Multiple Segments (DIMS) Spectacle Lens that could correct myopia and astigmatism.
Test for antibiotic associated kidney damage in children with CF identified europeanpharmaceuticalreview
April 02, 2018
New research highlights effective methods for identifying a common side effect in children receiving drug treatments for Cystic fibrosis…
Brain trauma in children linked to increased risk for ADHD biospectrumasia
March 23, 2018
Traumatic brain injury sends over 1 million kids, young adults to hospital annually
Study weighs risks and benefits of phase I trials in pediatric cancer worldpharmanews
February 28, 2018
On average, 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-related complication
Cancer drugs could transform the lives of children with AVM europeanpharmaceuticalreview
February 28, 2018
Drugs normally used to treat cancer could reduce the disfigurements of thousands of children born with life-threatening blood vessel defects…
Report shows less asthma attacks in US children pharmaceutical-technology
February 08, 2018
A new report by the US Centers for Disease Control and Prevention (CDC) has shown that children with asthma are having fewer attacks and less visits to the hospital.
NICE backs Humira, Enbrel and Stelara for plaque psoriasis in children pharmatimes
July 17, 2017
AbbVie’s Humira, Pfizer’s Enbrel, and Janssen’s Stelara are being recommended as options for treating plaque psoriasis in children and young people on the NHS.
EU grants marketing approval for children’s cancer immunotherapy drug financialexpress
May 16, 2017
The drug ‘Dinutuximab beta Apeiron’ improves the survival and chances for cure in the severe paediatric cancer neuroblastoma

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page